CCR5 and digestive system cancer: Higher levels of TGF-β and lower levels of IL-1β, CD14, and CCR5, markers of circulating neutrophils, suggest that TOLLIP deficiency may facilitate the resolution of chronic inflammation during colon carcinogenesis [36].